Shandong Xinhua Pharmaceutical Company Limited
Research Shandong Xinhua Pharmaceutical Company Limited (0719.HK) on Bullrun: market cap HKD 3.83B, P/E 15.7, dividend yield 3.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0719.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 3.83B
- P/E15.7
- Dividend yield3.1%
- Financial periodQ1 2026
- RevenueCNY 2.42B
- Net incomeCNY 83.90M
- Free cash flow-CNY 143.98M
- Gross margin18.2%
Valuation Snapshot
latest market cap is HKD 3.83B; P/E is 15.7; dividend yield is 3.1%.
Peer valuation comparison
Latest P/E is 15.7x versus a Healthcare sector median of 21.75x (27.8% below).
Latest dividend yield is 3.14% versus a Healthcare sector median of 2.4% (30.8% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 3.83B | 15.7 | 3.1% | 0.17 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.17 HKD, yield 3.1%.
About Shandong Xinhua Pharmaceutical Company Limited
Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. It offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Shandong Xinhua Pharmaceutical Company Limited's market cap?
Shandong Xinhua Pharmaceutical Company Limited's market capitalization is HKD 3.83B.
What is Shandong Xinhua Pharmaceutical Company Limited's P/E ratio?
Shandong Xinhua Pharmaceutical Company Limited's price-to-earnings (P/E) ratio is 15.7.
Does Shandong Xinhua Pharmaceutical Company Limited pay a dividend?
Shandong Xinhua Pharmaceutical Company Limited has a dividend yield of 3.1%.
What does Shandong Xinhua Pharmaceutical Company Limited do?
Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. It offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics.